Terms: = Uterine cancer AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1 AND Treatment
42 results:
1. Evaluating the Prognostic Factors and Survival Rates of Endometrial cancer Patients in a Tertiary Referral Hospital in Northeast Thailand.
Wannasin R; Thinkhamrop K; Kelly M; Likitdee N
Asian Pac J Cancer Prev; 2024 Feb; 25(2):671-679. PubMed ID: 38415555
[TBL] [Abstract] [Full Text] [Related]
2. Development and adaptations of the Graded Prognostic Assessment (GPA) scale: a systematic review.
Ribeiro LM; Bomtempo FF; Rocha RB; Telles JPM; Neto EB; Figueiredo EG
Clin Exp Metastasis; 2023 Dec; 40(6):445-463. PubMed ID: 37819546
[TBL] [Abstract] [Full Text] [Related]
3. Cervical HPV infection in Yueyang, China: a cross-sectional study of 125,604 women from 2019 to 2022.
Hou J; Zeng M; Liu C; Xie B; Li Y; Wu L; Zhu L; Li M; Zhang Z; Zhang X; Ge Y
Front Public Health; 2023; 11():1210253. PubMed ID: 37601194
[TBL] [Abstract] [Full Text] [Related]
4. Cytotoxic Effects of Combinative ZnPcS
Razlog R; Kruger CA; Abrahamse H
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047123
[TBL] [Abstract] [Full Text] [Related]
5. Erdheim-Chester Disease Involving the Left uterine Adnexa: Mimicking an Ovarian Carcinoma Clinically.
Zeng Y; Wang Q; Wang X; Jiang X; Yao H; Tang X
Int J Surg Pathol; 2023 Dec; 31(8):1532-1537. PubMed ID: 36855299
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of Effectiveness as well as Advantages and Disadvantages of Different Dimensions of Hysterosalpingo-Contrast Sonography for Diagnosis of Lesions Associated with Female Infertility.
Pei R
Comput Math Methods Med; 2022; 2022():7508880. PubMed ID: 36164612
[TBL] [Abstract] [Full Text] [Related]
7. Cervical cancer management in Zimbabwe (2019-2020).
Zibako P; Tsikai N; Manyame S; Ginindza TG
PLoS One; 2022; 17(9):e0274884. PubMed ID: 36129898
[TBL] [Abstract] [Full Text] [Related]
8. Relugolix Combination Therapy for uterine Leiomyoma-Associated Pain in the LIBERTY Randomized Trials.
Stewart EA; Lukes AS; Venturella R; Arjona Ferreira JC; Li Y; Hunsche E; Wagman RB; Al-Hendy A
Obstet Gynecol; 2022 Jun; 139(6):1070-1081. PubMed ID: 35675604
[TBL] [Abstract] [Full Text] [Related]
9. Trends in guideline-adherent chemoradiation therapy for locally advanced cervical cancer before and after the affordable care act.
Thomas RJ; Provenzano D; Goyal S; Loew M; Lopez-Acevedo M; Long B; Chappell NP; Rao YJ
Gynecol Oncol; 2022 Jul; 166(1):165-172. PubMed ID: 35491268
[TBL] [Abstract] [Full Text] [Related]
10. Histone deacetylase inhibition by suberoylanilide hydroxamic acid: a therapeutic approach to treat human uterine leiomyoma.
Carbajo-García MC; García-Alcázar Z; Corachán A; Monleón J; Trelis A; Faus A; Pellicer A; Ferrero H
Fertil Steril; 2022 Feb; 117(2):433-443. PubMed ID: 34809976
[TBL] [Abstract] [Full Text] [Related]
11. MEK inhibition overcomes resistance to EphA2-targeted therapy in uterine cancer.
Wu Y; Huang J; Ivan C; Sun Y; Ma S; Mangala LS; Fellman BM; Urbauer DL; Jennings NB; Ram P; Coleman RL; Hu W; Sood AK
Gynecol Oncol; 2021 Oct; 163(1):181-190. PubMed ID: 34391578
[TBL] [Abstract] [Full Text] [Related]
12. Clear cell endometrial carcinomas with mismatch repair deficiency have a favorable prognosis: A systematic review and meta-analysis.
Travaglino A; Raffone A; Santoro A; Raimondo D; Angelico G; Valente M; Arciuolo D; Scaglione G; D'alessandris N; Casadio P; Inzani F; Mollo A; Seracchioli R; Zannoni GF
Gynecol Oncol; 2021 Sep; 162(3):804-808. PubMed ID: 34266691
[TBL] [Abstract] [Full Text] [Related]
13. Glioblastoma in a female neurofibromatosis 1 patient without IDH1, braf V600E, and TERT promoter mutations: A case report.
Cai JW; Chen XY; Chen JY; Wu ZY; Wu XY; Yu LH; You HH
Medicine (Baltimore); 2021 Apr; 100(13):e25346. PubMed ID: 33787635
[TBL] [Abstract] [Full Text] [Related]
14. Guideline-adherent treatment, sociodemographic disparities, and cause-specific survival for endometrial carcinomas.
Rodriguez VE; LeBrón AMW; Chang J; Bristow RE
Cancer; 2021 Jul; 127(14):2423-2431. PubMed ID: 33721357
[TBL] [Abstract] [Full Text] [Related]
15. Dasatinib, paclitaxel, and carboplatin in women with advanced-stage or recurrent endometrial cancer: A pilot clinical and translational study.
Coleman RL; Hu W; Soliman P; Nick A; Ramirez PT; Westin SN; Garcia ME; Zhu Z; Palancia J; Fellman BM; Yuan Y; Ram P; Bischoff F; Schmeler K; Bodurka D; Meyer LA; Sood AK
Gynecol Oncol; 2021 Apr; 161(1):104-112. PubMed ID: 33551196
[TBL] [Abstract] [Full Text] [Related]
16. Guideline No. 408: Management of Gestational Trophoblastic Diseases.
Eiriksson L; Dean E; Sebastianelli A; Salvador S; Comeau R; Jang JH; Bouchard-Fortier G; Osborne R; Sauthier P
J Obstet Gynaecol Can; 2021 Jan; 43(1):91-105.e1. PubMed ID: 33384141
[TBL] [Abstract] [Full Text] [Related]
17. Dynamic analysis of circulating tumor DNA to predict prognosis and monitor therapeutic response in metastatic relapsed cervical cancer.
Tian X; Ge D; Zhang F; Zhang B; Bai W; Xu X; Li Z; Cao Y; Li P; Zou K; Zou L
Int J Cancer; 2021 Feb; 148(4):921-931. PubMed ID: 33113150
[TBL] [Abstract] [Full Text] [Related]
18. Multiparametric MRI-Based Radiomics Nomogram for Predicting Lymphovascular Space Invasion in Endometrial Carcinoma.
Luo Y; Mei D; Gong J; Zuo M; Guo X
J Magn Reson Imaging; 2020 Oct; 52(4):1257-1262. PubMed ID: 32315482
[TBL] [Abstract] [Full Text] [Related]
19. The cancer cell proteome and transcriptome predicts sensitivity to targeted and cytotoxic drugs.
Rydenfelt M; Wongchenko M; Klinger B; Yan Y; Blüthgen N
Life Sci Alliance; 2019 Aug; 2(4):. PubMed ID: 31253656
[TBL] [Abstract] [Full Text] [Related]
20. High expression of survivin predicts poor prognosis in cervical squamous cell carcinoma treated with paclitaxel and carboplatin.
Zhang Y; Yan H; Li R; Guo Y; Zheng R
Medicine (Baltimore); 2019 May; 98(20):e15607. PubMed ID: 31096466
[TBL] [Abstract] [Full Text] [Related]
[Next]
